Resonetics said today that it has purchased Hudson Medical Innovations from Preco.
Hudson manufactures microfluidics, point-of-care diagnostics (including application of reagents), biosensors, and advanced wound care devices. The company was founded in 2012 and is headquartered in Hudson, Wisconsin.
Resonetics said Hudson’s responsive prototyping capabilities and proprietary, automated equipment helped build its reputation as a supplier that supports customers with precise products from development to high-volume production.
“Hudson Medical Innovations is utilizing many of the same principles that have driven Resonetics’ growth: a focus on the customer, innovative problem solving, and purpose-built equipment to scale production efficiently,” Resonetics President and CEO Tom Burns said in a news release. “The Hudson team has established a great position serving leading customers in very exciting high-growth markets, expanding the breadth and diversity of Resonetics.”
The closed deal is Resonetics’ tenth acquisition in five years, following the FISO Technologies deal announced last week. Backed by Chicago-based private equity firm GTCR, the Nashua, New Hampshire-based life science engineering and manufacturing company has more than 1,600 employees and more than 600,000 square feet of facility space across 13 sites.